glp 1 agonist pcos The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome The Role of Glp-1 Receptor

The details: In March 2024, Altimmune announced the results of MOMENTUM, a phase 2 trial in which people received weekly injections of pemvidutide as an obesity treatment

The information contained herein is not intended to replace or substitute for conventional medical care or encourage its abandonment.

Current evidence suggests GLP-1 receptor agonists have a neutral effect on fracture risk, though bone mineral density changes may occur indirectly through substantial weight loss

doi: 10.1056/NEJMoa1607141 [DOI] [PubMed] [Google Scholar] 9

Declaration of Helsinki: ethical principles for medical research involving human subjects

Back Eckert, N (1 Dec 2023) 'What Is the dark side of GLP-1 receptor agonists?' Medscape Medical News